報價延遲最少15分鐘:2026/09/19 12:40 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.69 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.21/-0.37
|
|
企業價值
539.29M
|
| 資產負債 |
|
每股賬面淨值
1.07
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
7.25M
|
|
每股收益
0.00
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with apotential best-in-class mechanism of action. |
